Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CMA1 | P23946 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30852861 | 0.92 | KMT2A (0.36) | CMA1KMT2ASMN1; SMN2PTPN1REN | |
| SCHEMBL30028577 | 0.86 | KMT2A (0.45) | CMA1KMT2ASMN1; SMN2ITGB1ITGA4 | |
| SCHEMBL30138992 | 0.85 | CAPN1 (0.40) | OPRM1OPRD1ITGB1ITGA4ACE | |
| SCHEMBL30543475 | 0.84 | GRB2 (0.41) | CMA1KMT2APTPN1OPRM1OPRD1 | |
| SCHEMBL30730414 | 0.82 | CALCRL (0.38) | CMA1KMT2AITGB3ITGA2BREN | |
| SCHEMBL31031470 | 0.82 | CAPN1 (0.38) | ITGB3ITGA2BOPRM1OPRD1ITGB1 | |
| SCHEMBL31347345 | 0.82 | CMA1 (0.37) | CMA1KMT2AITGB3ITGA2BOPRM1 | |
| SCHEMBL29699495 | 0.82 | KMT2A (0.43) | CMA1KMT2ARENITGB1ITGA4 | |
| SCHEMBL29816594 | 0.81 | PTGS1 (0.41) | ITGB3ITGA2BRENITGB1ITGA4 | |
| SCHEMBL30493192 | 0.81 | ITGB1 (0.36) | CMA1ITGB3ITGA2BITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113173987-B | Method for synthesizing linatide | 汉肽生物医药集团有限公司 | 2022-11-29 | — | — | CN | claimed |
| EP-4724472-A2 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252367-A2 | NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |